Brief: Evoke Pharma Reports Q4 And Full Year 2021 Financial Results

Evoke Pharma

08/03/2022 22:23

March 8 (Reuters) - Evoke Pharma Inc  EVOK.O :
    * EVOKE PHARMA REPORTS FOURTH QUARTER AND FULL YEAR 2021
FINANCIAL
RESULTS
    * Q4 LOSS PER SHARE $0.27
    * BELIEVE THAT EXISTING CASH AND CASH EQUIVALENTS, AND
FUTURE CASH
FLOWS WILL BE SUFFICIENT TO FUND OUR OPERATIONS INTO Q1 OF 2023

Source text for Eikon:  ID:nGNXccSxBH 
Further company coverage:  EVOK.O 

 ((Reuters.Briefs@thomsonreuters.com;))